Abstract:BackgroundThe expanded use of multiple drugs has increased the occurrence of adverse drug reactions (ADRs) induced by drug-drug interactions (DDIs). However, such reactions are typically not observed in clinical drug-development studies because most of them focus on single-drug therapies. ADR reporting systems collect information on adverse health effects caused by both single drugs and DDIs. A major challenge is to unambiguously identify the effects caused by DDIs and to attribute them to specific drug interactions. A computational method that provides prospective predictions of potential DDI-induced ADRs will help to identify and mitigate these adverse health effects.MethodWe hypothesize that drug-protein interactions can be used as independent variables in predicting ADRs. We constructed drug pair-protein interaction profiles for ~800 drugs using drug-protein interaction information in the public domain. We then constructed statistical models to score drug pairs for their potential to induce ADRs based on drug pair-protein interaction profiles.ResultsWe used extensive clinical database information to construct categorical prediction models for drug pairs that are likely to induce ADRs via synergistic DDIs and showed that model performance deteriorated only slightly, with a moderate amount of false positives and false negatives in the training samples, as evaluated by our cross-validation analysis. The cross validation calculations showed an average prediction accuracy of 89% across 1,096 ADR models that captured the deleterious effects of synergistic DDIs. Because the models rely on drug-protein interactions, we made predictions for pairwise combinations of 764 drugs that are currently on the market and for which drug-protein interaction information is available. These predictions are publicly accessible at http://avoid-db.bhsai.org. We used the predictive models to analyze broader aspects of DDI-induced ADRs, showing that ~10% of all combinations have the potential to induce ADRs via DDIs. This allowed us to identify potential DDI-induced ADRs not yet clinically reported. The ability of the models to quantify adverse effects between drug classes also suggests that we may be able to select drug combinations that minimize the risk of ADRs.ConclusionAlmost all information on DDI-induced ADRs is generated after drug approval. This situation poses significant health risks for vulnerable patient populations with comorbidities. To help mitigate the risks, we developed a robust probabilistic approach to prospectively predict DDI-induced ADRs. Based on this approach, we developed prediction models for 1,096 ADRs and used them to predict the propensity of all pairwise combinations of nearly 800 drugs to be associated with these ADRs via DDIs. We made the predictions publicly available via internet access.

A contemporary review of machine learning to predict adverse pregnancy outcomes from pharmaceuticals, including DDIs

Advanced AI-Driven Prediction of Pregnancy-Related Adverse Drug Reactions.

Development and validation of a machine learning algorithm for predicting the risk of postpartum depression among pregnant women

Using Electronic Health Records and Machine Learning to Predict Postpartum Depression.

FetoML: Interpretable predictions of the fetotoxicity of drugs based on machine learning approaches

Machine learning to predict pregnancy outcomes: a systematic review, synthesizing framework and future research agenda

A Machine Learning Model to Predict Drug Transfer Across the Human Placenta Barrier

Machine learning and disease prediction in obstetrics

Enabling pregnant women and their physicians to make informed medication decisions using artificial intelligence

Machine learning techniques for prediction in pregnancy complicated by autoimmune rheumatic diseases: Applications and challenges

Machine learning: a new era for cardiovascular pregnancy physiology and cardio-obstetrics research

Machine learning applied in maternal and fetal health: a narrative review focused on pregnancy diseases and complications

Towards deep phenotyping pregnancy: a systematic review on artificial intelligence and machine learning methods to improve pregnancy outcomes

Predicting adverse drug event using machine learning based on electronic health records: a systematic review and meta-analysis

Comparison of machine learning and logistic regression as predictive models for adverse maternal and neonatal outcomes of preeclampsia: A retrospective study

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

Machine learning to predict adverse drug events based on electronic health records: a systematic review and meta-analysis

Data-driven prediction of adverse drug reactions induced by drug-drug interactions

Recent development of machine learning models for the prediction of drug-drug interactions

In silico prediction of drug-induced developmental toxicity by using machine learning approaches

Machine Learning for Investigation on Endocrine-Disrupting Chemicals with Gestational Age and Delivery Time in a Longitudinal Cohort